机构:
Thomas Jefferson Univ, Jefferson Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USAThomas Jefferson Univ, Jefferson Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA
Pucci, B
[1
]
Kasten, M
论文数: 0引用数: 0
h-index: 0
机构:
Thomas Jefferson Univ, Jefferson Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USAThomas Jefferson Univ, Jefferson Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA
Kasten, M
[1
]
Giordano, A
论文数: 0引用数: 0
h-index: 0
机构:
Thomas Jefferson Univ, Jefferson Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USAThomas Jefferson Univ, Jefferson Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA
Giordano, A
[1
]
机构:
[1] Thomas Jefferson Univ, Jefferson Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA
来源:
NEOPLASIA
|
2000年
/
2卷
/
04期
关键词:
apoptosis;
cell cycle;
c-myc;
p53;
pRb;
Cdks;
D O I:
10.1038/sj.neo.7900101
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
In multicellular organisms, cell proliferation and death must be regulated to maintain tissue homeostasis, Many observations suggest that this regulation may be achieved, in part, by coupling the process of cell cycle progression and programmed cell death by using and controlling a shared set of factors. An argument in favor of a link between the cell cycle and apoptosis arises from the accumulated evidence that manipulation of the cell cycle may either prevent or induce an apoptotic response. This linkage has been recognized for tumor suppressor genes such as p53 and RS,the dominant oncogene, c-Myc, and several cyclin-dependent kinases (Cdks) and their regulators. These proteins that function in proliferative pathways may also act to sensitize cells to apoptosis. Indeed, unregulated cell proliferation can result in pathologic conditions including neoplasias if it is not countered by the appropriate cell death. Translating the knowledge gained by studying the connection between cell death and cell proliferation may aid in identifying novel therapies to circumvent disease progression or improve clinical outcome.
机构:
TOKYO MED & DENT UNIV,DIV MED RES,DEPT RETROVIRAL REGULAT,BUNKYO KU,TOKYO 113,JAPANTOKYO MED & DENT UNIV,DIV MED RES,DEPT RETROVIRAL REGULAT,BUNKYO KU,TOKYO 113,JAPAN
YOSHIDA, T
IKAWA, Y
论文数: 0引用数: 0
h-index: 0
机构:
TOKYO MED & DENT UNIV,DIV MED RES,DEPT RETROVIRAL REGULAT,BUNKYO KU,TOKYO 113,JAPANTOKYO MED & DENT UNIV,DIV MED RES,DEPT RETROVIRAL REGULAT,BUNKYO KU,TOKYO 113,JAPAN
IKAWA, Y
JAPANESE JOURNAL OF NEUROPSYCHOPHARMACOLOGY,
1995,
17
(06):
: 373
-
378